Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025
Kiniksa Pharmaceuticals (Nasdaq: KNSA) has scheduled its second quarter 2025 financial results conference call and webcast for Tuesday, July 29, 2025 at 8:30 a.m. Eastern Time. The company will discuss its Q2 2025 financial performance and recent portfolio developments.
Investors can access the live webcast through the Investors & Media section on www.kiniksa.com. For telephone participation, interested parties must pre-register to receive dial-in details. A replay will be available on the company's website within 48 hours after the event.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) ha programmato la conference call e il webcast dei risultati finanziari del secondo trimestre 2025 per martedì 29 luglio 2025 alle 8:30 AM ora Eastern. L'azienda discuterà le performance finanziarie del Q2 2025 e gli sviluppi recenti del portafoglio.
Gli investitori potranno seguire il webcast in diretta nella sezione Investors & Media su www.kiniksa.com. Per partecipare telefonicamente, è necessario registrarsi in anticipo per ricevere i dettagli di accesso. Una registrazione sarà disponibile sul sito web dell'azienda entro 48 ore dall'evento.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) ha programado su llamada y webcast para los resultados financieros del segundo trimestre de 2025 para el martes 29 de julio de 2025 a las 8:30 a.m. hora del Este. La compañía discutirá su desempeño financiero del Q2 2025 y los desarrollos recientes en su cartera.
Los inversores pueden acceder al webcast en vivo a través de la sección Investors & Media en www.kiniksa.com. Para participar por teléfono, los interesados deben registrarse previamente para recibir los detalles de acceso. Una repetición estará disponible en el sitio web de la compañía dentro de las 48 horas posteriores al evento.
Kiniksa Pharmaceuticals (나스닥: KNSA)는 2025년 2분기 재무실적 컨퍼런스 콜 및 웹캐스트를 2025년 7월 29일 화요일 오전 8시 30분(동부시간)에 예정했습니다. 회사는 2025년 2분기 재무 성과와 최근 포트폴리오 개발 사항을 논의할 예정입니다.
투자자들은 www.kiniksa.com의 Investors & Media 섹션을 통해 라이브 웹캐스트에 접속할 수 있습니다. 전화 참여를 원할 경우, 사전 등록을 통해 전화 접속 정보를 받아야 합니다. 행사 후 48시간 이내에 회사 웹사이트에서 다시보기가 제공됩니다.
Kiniksa Pharmaceuticals (Nasdaq : KNSA) a programmé sa conférence téléphonique et webcast des résultats financiers du deuxième trimestre 2025 pour le mardi 29 juillet 2025 à 8h30, heure de l’Est. La société discutera de ses performances financières du T2 2025 ainsi que des développements récents de son portefeuille.
Les investisseurs peuvent accéder au webcast en direct via la section Investors & Media sur www.kiniksa.com. Pour participer par téléphone, il est nécessaire de s’inscrire à l’avance afin de recevoir les détails d’accès. Une rediffusion sera disponible sur le site internet de la société dans les 48 heures suivant l’événement.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) hat seine Telefonkonferenz und Webcast zu den Finanzergebnissen des zweiten Quartals 2025 für Dienstag, den 29. Juli 2025 um 8:30 Uhr Eastern Time angesetzt. Das Unternehmen wird die finanzielle Leistung des Q2 2025 sowie aktuelle Entwicklungen im Portfolio besprechen.
Investoren können den Live-Webcast über den Bereich Investors & Media auf www.kiniksa.com verfolgen. Für die telefonische Teilnahme ist eine vorherige Registrierung erforderlich, um Einwahldaten zu erhalten. Eine Aufzeichnung wird innerhalb von 48 Stunden nach der Veranstaltung auf der Unternehmenswebsite verfügbar sein.
- None.
- None.
LONDON, July 24, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, July 29, 2025 at 8:30 a.m. Eastern Time to report its second quarter 2025 financial results and recent portfolio execution.
A live webcast will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. Individuals interested in participating in the call via telephone may register here. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.
About Kiniksa
Kiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa’s portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. For more information, please visit www.kiniksa.com.
Every Second Counts! ®
Kiniksa Investor & Media Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com
FAQ
When is Kiniksa Pharmaceuticals (KNSA) reporting Q2 2025 earnings?
How can investors access Kiniksa's Q2 2025 earnings call?
Will there be a replay available of Kiniksa's Q2 2025 earnings call?
What topics will be covered in Kiniksa's Q2 2025 earnings call?
